Cargando…

Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent

BACKGROUND: The World Health Organization (WHO) announced the COVID-19 occurrence as a global pandemic in March 2020. The treatment of SARS-CoV-2 patients is based on the experience gained from SARS-CoV and MERS-CoV infection during 2003. There is no clinically accepted therapeutic drug(s) accessibl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Vijay K., Shirbhate, Ekta, Patel, Preeti, Veerasamy, Ravichandran, Sharma, Prabodh C., Rajak, Harish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567120/ https://www.ncbi.nlm.nih.gov/pubmed/34751250 http://dx.doi.org/10.1186/s43088-021-00165-0

Ejemplares similares

Coronavirus reinfections: An outlook on evidences and effects
por: Patel, Vijay K., et al.
Publicado: (2022)

Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
por: Shirbhate, Ekta, et al.
Publicado: (2021)

Structure–Activity Relationship Analysis of Benzimidazoles as Emerging Anti-Inflammatory Agents: An Overview
por: Veerasamy, Ravichandran, et al.
Publicado: (2021)

Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects
por: Singh, Avineesh, et al.
Publicado: (2016)

Synthesis and characterization of N-Mannich based prodrugs of ciprofloxacin and norfloxacin: In vitro anthelmintic and cytotoxic evaluation
por: Piplani, Mona, et al.
Publicado: (2017)

Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach
por: Veerasamy, Ravichandran, et al.
Publicado: (2022)

CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020)

Corticosteroids and ARDS: A review of treatment and prevention evidence
por: Khilnani, G.C., et al.
Publicado: (2011)

Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients
por: Mandadi, Subhadra, et al.
Publicado: (2022)

Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients
por: Bhadania, Simple, et al.
Publicado: (2021)

Phyto-Mediated Photo Catalysed Green Synthesis of Silver Nanoparticles Using Durio Zibethinus Seed Extract: Antimicrobial and Cytotoxic Activity and Photocatalytic Applications
por: Sumitha, Samuggam, et al.
Publicado: (2018)

The Rationale for Using Corticosteroids in COVID-19 Encephalopathy: Lessons From a Case Report With Evidence From Literature
por: Ameer, Muhammad Atif, et al.
Publicado: (2023)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Corticosteroids in severe COVID-19: a critical view of the evidence
por: De Backer, Daniel, et al.
Publicado: (2020)

COVID-19 treatment corticosteroids-induced mania
por: Galvañ, J., et al.
Publicado: (2022)

Corticosteroids for COVID-19
por: Annane, Djillali
Publicado: (2021)

Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis
por: Sarfraz, Azza, et al.
Publicado: (2021)

Does the extent of collaterals influence the severity of the myocardial injury as assessed by elevation in biomarkers?
por: Dubey, Gajendra, et al.
Publicado: (2021)

DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication
por: Ravichandran, Veerasamy, et al.
Publicado: (2008)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
por: Coelho, Luís, et al.
Publicado: (2023)

Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19
por: Mun, Chan Sook, et al.
Publicado: (2022)

Expectation management of policy leaders: Evidence from COVID-19()
por: Haan, Peter, et al.
Publicado: (2022)

Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence
por: Magala Ssekandi, Abdul, et al.
Publicado: (2021)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Corticosteroids for COVID-19: worth it or not?
por: Akter, Fariya, et al.
Publicado: (2021)

Investigation of carbon emissions due to COVID-19 vaccine inventory
por: Shah, Nita H., et al.
Publicado: (2021)

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
por: Nicolau, Dan V, et al.
Publicado: (2020)

THE INCIDENCE OF NEW-ONSET ATRIAL FIBRILLATION IN HOSPITALIZED COVID-19 PATIENTS RECEIVING HIGH DOSE CORTICOSTEROIDS
por: McMahan, Daniel, et al.
Publicado: (2022)

Emerging Role of Flavonoids as the Treatment of Depression
por: Pannu, Arzoo, et al.
Publicado: (2021)

COVID-19 and market expectations: Evidence from option-implied densities
por: Hanke, Michael, et al.
Publicado: (2020)

Can lip prints provide biologic evidence?
por: Sharma, Preeti, et al.
Publicado: (2016)

Recent advances in the vaccine development for the prophylaxis of SARS Covid-19
por: Kumar, Vipul, et al.
Publicado: (2022)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

The use of corticosteroids for COVID-19 infection
por: Richards, G A, et al.
Publicado: (2020)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

Antenatal corticosteroids in COVID-19 perspective
por: Vidaeff, Alex C, et al.
Publicado: (2021)

Corticosteroids in COVID-19: pros and cons
por: Bahsoun, Aymen, et al.
Publicado: (2023)

Expectations when you are expecting in times of COVID-19
por: Miranda, Debora M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t4f3jdboufsf1iko4hc5t49qod